Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dual-AAV mini-dystrophin (Cfa intein)
- Development stage
- Preclinical
- Lead developer
- Instituto de Biologia Experimental e Tecnológica (iBET)
- Modality
- Gene Therapies
01
Overview
**Dual-AAV mini-dystrophin Cfa intein** is a research-stage, dual-vector adeno-associated virus gene-therapy construct designed to address the limited packaging capacity of AAV for dystrophin replacement. Two AAV vectors each deliver a portion of a mini-dystrophin coding sequence fused to complementary fragments of the engineered **Cfa split intein**. Following co-transduction of muscle cells, Cfa-mediated protein trans-splicing is intended to join the two translated mini-dystrophin fragments into a reconstituted therapeutic protein. The construct was described in an ASGCT 2026 abstract as one of several split-intein approaches evaluated in murine myotubes and human induced pluripotent stem cell-derived skeletal-muscle models. It is not presented as a sponsor-named clinical candidate, and the exact AAV capsid, mini-dystrophin sequence, dose, and clinical route were not specified.
- Other names
- dual-AAV mini-dystrophin Cfa intein
02
Targets
F-actin (Filamentous actin)DMD (Dystrophin)
Beyond the preview
Go deeper on dual-AAV mini-dystrophin (Cfa intein).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dual-AAV mini-dystrophin (Cfa intein).